# Denis Shafranik

> Denis Shafranik is a seed investor at Concentric (London) backing Internet and Health Care. See 33 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Concentric](https://shizune.co/investors/profile/concentric)
- Location: London, United Kingdom
- Total investments: 33
- Last investment: May 2026
- Lead investor: 52%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/denisshafranik
- Website: http://concentric.vc/people/denis-shafranik/
- Facebook: http://www.facebook.com/shafranik

Denis Shafranik is a seed investor at Concentric in London focused on Internet and Health Care. Denis Shafranik is co-founder of Concentric; an activist venture fund with a focus on partnering with early-stage software businesses augmenting real economy sectors. Denis Shafranik spent 9 years in investment banking. He graduated from the London School of Economics, obtained an EMBA from INSEAD, and is a CFA charter.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Internet | 3 | 9% |
| Health Care | 3 | 9% |
| Billing | 2 | 6% |
| FinTech | 2 | 6% |
| Finance | 2 | 6% |

52 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Seed | 9 | 27% |
| Series A | 7 | 21% |
| Series B | 5 | 15% |
| Funding Round | 2 | 6% |
| Convertible Note | 1 | 3% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United Kingdom | 8 | 24% |
| Germany | 2 | 6% |
| Chile | 1 | 3% |
| Brazil | 1 | 3% |
| Mexico | 1 | 3% |

7 countries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Visium | Visium is a consulting company specialized in artificial intelligence, machine learning, and consulting. It delivers value to companies at every level of AI development, whether they are just entering the field or have a solid data science department. The company was founded in 2018 and headquartered in Zurich, Switzerland. |  |  | May 20, 2026 |  |
| Transcend Therapeutics | Transcend Therapeutics is a clinical-stage biotechnology company focused on developing rapid-acting treatments for neuropsychiatric diseases. The company aims to address mental health conditions such as post-traumatic stress disorder (PTSD) and major depressive disorder (MDD), particularly for patients who do not respond to existing therapies. Thecompany’s lead program, TSND-201 (methylone), is being developed as a next-generation neuroplastogen designed to deliver fast and durable therapeutic effects. Its research emphasizes innovative psychoactive compounds that can improve outcomes while minimizing common limitations of traditional psychiatric medications. Backed by venture funding and an experienced leadership team with multiple FDA approvals, Transcend Therapeutics continues to advance clinical trials and expand its pipeline of mental health treatments. |  | Convertible Note | Oct 28, 2024 |  |
| Koywe | Koywe provides payment APIs and SDKs so that any company can start leveraging crypto to offer remittances, wallets, and investment services. | $5M | Seed | Aug 01, 2024 |  |
| Beckley Psytech | Beckley Psytech operates as a psychedelic medicine company. The company is involved in exploring the therapeutic potential of psychedelic substances, such as psilocybin and other compounds, for mental health treatment. The company envisions the integration of clinically validated psychedelic medicines into contemporary medical practices to assistindividuals coping with depression and other significantly debilitating neuropsychiatric conditions characterized by a substantial unmet need. | $40M |  | Jan 04, 2024 |  |
| Superscript | Superscript provides business insurance designed specifically to meet the fast-changing needs of small businesses. Underpinned by proprietary technology, expertise in emerging risks and threats, and partnerships with some of the world’s biggest underwriters, it delivers bespoke, subscription-based insurance cover for all types of risk. Superscriptshapes business protection around businesses’ individual needs, from essential cover through to complex risks. It delivers a personalised customer experience that supports the ever-evolving needs of small to medium-sized businesses. Superscript was originally founded as Digital Risks in 2015 and is based in London, England. | $54.8M | Series B | Jan 09, 2023 |  |
| Escola Britanica de Artes Criativas | Higher Education - Art, Design | $11M | Series A | Nov 01, 2021 |  |
| Merama | Merama is an e-commerce platform that partners and exponentiates the growth of each brand they work with. The platform helps fuel their business with outstanding human resources and non-dilutive capital. Its mission is to be the best and largest online group of brands in Latin America.Merama was founded in 2020 and is headquartered in MexicoCity, Mexico. | $225M | Series B | Sep 28, 2021 |  |
| Pockit | Pockit is a fintech business that focuses on providing financial services primarily to customers who are typically excluded or at least underserved by high street banks. It provides a digital banking app designed to cater to the underbanked masses. | $19.1M | Series B | Dec 03, 2020 |  |
| Superscript | Superscript provides business insurance designed specifically to meet the fast-changing needs of small businesses. Underpinned by proprietary technology, expertise in emerging risks and threats, and partnerships with some of the world’s biggest underwriters, it delivers bespoke, subscription-based insurance cover for all types of risk. Superscriptshapes business protection around businesses’ individual needs, from essential cover through to complex risks. It delivers a personalised customer experience that supports the ever-evolving needs of small to medium-sized businesses. Superscript was originally founded as Digital Risks in 2015 and is based in London, England. | $10.8M | Series A | Oct 29, 2020 |  |
| Superscript | Superscript provides business insurance designed specifically to meet the fast-changing needs of small businesses. Underpinned by proprietary technology, expertise in emerging risks and threats, and partnerships with some of the world’s biggest underwriters, it delivers bespoke, subscription-based insurance cover for all types of risk. Superscriptshapes business protection around businesses’ individual needs, from essential cover through to complex risks. It delivers a personalised customer experience that supports the ever-evolving needs of small to medium-sized businesses. Superscript was originally founded as Digital Risks in 2015 and is based in London, England. | $10.4M | Series A | Feb 26, 2020 |  |

10 of 33 investments shown.

## Co-investors
- [Kinled Holding](https://shizune.co/investors/profile/kinled) — VC Fund, 5 deals together
- [AlbionVC](https://shizune.co/investors/profile/albion-vc) — VC Fund, 4 deals together
- [London Co-Investment Fund](https://shizune.co/investors/profile/london-co-investment-fund) — VC Fund, 4 deals together
- [Seedcamp](https://shizune.co/investors/profile/seedcamp) — VC Fund, 4 deals together
- [BHL Holdings](https://shizune.co/investors/profile/bhl-holdings) — VC Fund, 3 deals together
- [14W](https://shizune.co/investors/profile/14-w) — VC Fund, 2 deals together

## About Concentric

VC Fund · London, United Kingdom

Concentric invests in software technology business in the financial services, mobility, real estate, industrial, and logistics sectors.

5 contacts available at Concentric.

| Name | Title | Profile |
| --- | --- | --- |
| Kjartan Rist | Founding Partner | https://shizune.co/investors/profile/kjartan-rist |
| Alexander Mann | Principal | https://shizune.co/investors/profile/alexander-mann |
| Alexander Stroud | Principal | https://shizune.co/investors/profile/alexander-stroud |
| Denis Shafranik | Partner & Co-Founder | https://shizune.co/investors/profile/denis-shafranik |
| Ilya Belyaev | Venture Partner | https://shizune.co/investors/profile/ilya-belyaev |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does Denis Shafranik invest in?

Denis Shafranik invests primarily in Internet, Health Care and Billing startups, most often at Seed and Series A stage. Most of the 33 investments tracked by Shizune back companies in United Kingdom. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Denis Shafranik last invest?

The most recent investment recorded for Denis Shafranik closed in May 2026. Shizune tracks 33 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co